Delphine BADINAND
MD
-
Onco-radiotherapist at the Timone Hospital
APHM
MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.
Cancerology is booming and immunotherapy represents the most promising approach. At the APHM we have been at the forefront of these therapeutic advances and as a radiotherapist, I’m developing new strategies combining radiotherapy and immunotherapy to reach the « abscopal effect ». MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.
#clinicHave a look on our testimonies
MI COMMUNITY
Thanks to this unprecedented alliance of researchers, clinicians, technological platforms and industrials we should be able to quickly do much better
Vincent BARLOGIS
AP-HM
MI COMMUNITY
A therapeutic revolution is happening.
Bertrand NADEL
CIML, Canceropôle PACA
MI COMMUNITY
As such, we are involved in the Marseille immunology biotope
Michel MANCIS
Protisvalor
MI COMMUNITY
Immunotherapy is expanding to other cancers types: kidney cancer, bladder cancer, hepatocellular carcinoma, Hodgkin’s lymphoma, non-Hodgkin’s lymphoma… but we are still only at the beginning of the story!
Mondher MAHJOUBI
Innate Pharma
MI AND YOU Show
your commitment to MI
your commitment to MI